 |
|
Head and neck cancers
50 patients suffering predominantly from tumours of the larynx and pharynx (as well as several salivary gland and soft tissue cases) were treated with Avemar. The quality of life improved (relief of cachectic symptoms, increase of body weight). Five salivary gland tumour patients remained tumour free on a long-term basis.
Conclusions: the relief of cachectic symptoms and increase in body weight can be explained to a certain extent by mechanisms already known, but, in any case, provide, along with its QOL effects, good reasons for using Avemar in oncological therapy.
|
 |
|
 |
